<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00138775</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-03-3093-MW-CTIL</org_study_id>
    <nct_id>NCT00138775</nct_id>
  </id_info>
  <brief_title>Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia</brief_title>
  <official_title>D-Serine Adjuvant Pharmacotherapy for the Treatment of Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanley Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <brief_summary>
    <textblock>
      The goal of the present study is to evaluate the effect of D-serine, added to antipsychotic
      treatment, on negative and cognitive symptoms in schizophrenia.

      The investigators are hypothesizing that D-serine will improve cognitive functioning and
      negative symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2004</start_date>
  <completion_date>October 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SANS - Scale for the Assessment of Negative Symptoms - weeks 0, 8 and 16</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement and Treatment Research for Cognition in Schizophrenia (MATRICS) battery - visit weeks 0, 8 and 16</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Syndrome Scale of Schizophrenia (PANSS) positive, negative, general and total score - weeks 0, 8 and 16</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simpson-Angus Scale (SAS) total score - weeks 0, 8 and 16</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impressions (CGI) score - weeks 0, 8 and 16</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calgary Depression Scale for Schizophrenia (CDSS) score - weeks 0, 8 and 16</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effect check list</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>D-serine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV)
             diagnosis of schizophrenia and\or schizoaffective disorder.

          -  Age between 18 to 64.

          -  PANSS negative symptom score higher than 19.

          -  SAS total score lower than 12.

          -  CDSS suicidal risk lower than 2

        Exclusion Criteria:

          -  Epilepsy

          -  Meets DSM-IV criteria for mental retardation.

          -  Medical condition which confounds presentation or treatment (e.g. uncontrolled
             diabetes mellitus, history of kidney stones, acute drug toxicity, dementia, delirium,
             stroke, etc.)

          -  Meets DSM-IV criteria for alcohol or drug dependence in last 6 months.

          -  Meets DSM-IV criteria for alcohol or drug abuse in last one month.

          -  Treatment with clozapine.

          -  Current positive pregnancy test or not using acceptable method of birth control.

          -  Meets DSM-IV criteria for current anxiety or mood disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Weiser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Weiser, MD</last_name>
    <phone>++972-352-6666575</phone>
    <email>mweiser@netvision.net.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ha-Emek Medical Center</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilana Kremer, MD</last_name>
      <phone>++972-46494350</phone>
      <email>kremer@aviv-pcb.com</email>
    </contact>
    <investigator>
      <last_name>Ilana Kremer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mazra Mental Health Center</name>
      <address>
        <city>Akko</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Liba, MD</last_name>
      <phone>++972-49559644</phone>
      <email>dliba1@netvision.net.il</email>
    </contact>
    <investigator>
      <last_name>David Liba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abarbanel Mental Health Center</name>
      <address>
        <city>Bat Yam</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Motti Mashiah, MD</last_name>
      <phone>++972-35552604</phone>
    </contact>
    <investigator>
      <last_name>Motti Mashiah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beer-Yaacov Mental Health Center</name>
      <address>
        <city>Beer-Yaacov</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yehuda Abramovitch, MD</last_name>
      <phone>++972-89258221</phone>
      <email>byabramovitch@beer-ness.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Yehuda Abramovitch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shalvata Mental Health Center</name>
      <address>
        <city>Hod Hasharon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yehiel Levkovitch, MD</last_name>
      <phone>++972-97478568</phone>
      <email>ylev@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Yehiel Levkovitch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kfar Shaul Psychiatric Hospital</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Teitelbaum, MD</last_name>
      <phone>++972-26448780</phone>
      <email>teital@barak-online.net</email>
    </contact>
    <investigator>
      <last_name>Alexander Teitelbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Sarah Herzog Memorial Hospital</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uriel Heresco-Levy, MD</last_name>
      <phone>++972-25316906</phone>
      <email>heresco@md2.huji.ac.il</email>
    </contact>
    <investigator>
      <last_name>Uriel Heresco-L</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nes-Ziona Mental Health Center</name>
      <address>
        <city>Nes Ziona</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Amital, MD</last_name>
      <phone>++972-50-8647067</phone>
    </contact>
    <investigator>
      <last_name>Daniela Amital, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lev Hasharon Mental Health Center</name>
      <address>
        <city>Pardesiyya</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitri Rudinski, MD</last_name>
      <phone>++972-98981210</phone>
      <email>drudinski@lev-hasaron.co.il</email>
    </contact>
    <investigator>
      <last_name>Dimitri Rudinski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geha Mental Health Center</name>
      <address>
        <city>Petah Tiqwa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shai Konas, MD</last_name>
      <phone>++972-50-7215226</phone>
      <email>konass@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Shai Konas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Weiser, MD</last_name>
      <phone>++972-52-6666576</phone>
      <email>mweiser@netvision.net.il</email>
    </contact>
    <investigator>
      <last_name>Mark Weiser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaar Menashe Mental Health Center</name>
      <address>
        <city>Shaar Menashe</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shmuel Hirschmann, MD</last_name>
      <email>hirscmann@shaar-menashe.org.il</email>
    </contact>
    <investigator>
      <last_name>Shmuel Hirschman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jaffa Mental Health Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yosef Zimerman, MD</last_name>
      <phone>++972-35151117</phone>
      <email>zimermanj@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Yosef Zimerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maccabi Mental Health Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yerechmiel Barber, MD</last_name>
      <phone>++972-35122196</phone>
      <email>ybarber@hotmail.co.il</email>
    </contact>
    <investigator>
      <last_name>Yerechmiel Barber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2005</study_first_submitted>
  <study_first_submitted_qc>August 28, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2005</study_first_posted>
  <last_update_submitted>December 24, 2006</last_update_submitted>
  <last_update_submitted_qc>December 24, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 27, 2006</last_update_posted>
  <keyword>D-serine</keyword>
  <keyword>Negative symptoms</keyword>
  <keyword>Cognition</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>Amino acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

